MDPI and ACS Style
Softah, A.; Alotaibi, M.R.; Alhoshani, A.R.; Saleh, T.; Alhazzani, K.; Almutairi, M.M.; AlRowis, R.; Alshehri, S.; Albekairy, N.A.; Harada, H.;
et al. The Combination of Radiation with PARP Inhibition Enhances Senescence and Sensitivity to the Senolytic, Navitoclax, in Triple Negative Breast Tumor Cells. Biomedicines 2023, 11, 3066.
https://doi.org/10.3390/biomedicines11113066
AMA Style
Softah A, Alotaibi MR, Alhoshani AR, Saleh T, Alhazzani K, Almutairi MM, AlRowis R, Alshehri S, Albekairy NA, Harada H,
et al. The Combination of Radiation with PARP Inhibition Enhances Senescence and Sensitivity to the Senolytic, Navitoclax, in Triple Negative Breast Tumor Cells. Biomedicines. 2023; 11(11):3066.
https://doi.org/10.3390/biomedicines11113066
Chicago/Turabian Style
Softah, Abrar, Moureq R. Alotaibi, Ali R. Alhoshani, Tareq Saleh, Khalid Alhazzani, Mashal M. Almutairi, Raed AlRowis, Samiyah Alshehri, Norah A. Albekairy, Hisashi Harada,
and et al. 2023. "The Combination of Radiation with PARP Inhibition Enhances Senescence and Sensitivity to the Senolytic, Navitoclax, in Triple Negative Breast Tumor Cells" Biomedicines 11, no. 11: 3066.
https://doi.org/10.3390/biomedicines11113066